About the Role
Massive Bio is seeking an Enrollment Delivery Manager to scale the operational engine that converts AI-matched patients into enrolled trial participants. This leadership role owns the enrollment funnel end-to-end, working across internal and external stakeholders to drive throughput and remove friction. As volume scales, you will build and manage a team of Project Managers.
Responsibilities
- Own the enrollment funnel end to end: qualification, site referral, screening, consent, and randomization.
- Work across internal teams (clinical operations, technology, customer success) and external stakeholders (sites, sponsors, CROs, site networks) to drive throughput and remove friction.
- Own enrollment outcomes and the processes behind them.
- Build and manage a team of Project Managers to expand delivery capacity as volume scales.
Requirements
- 5–8 years leading operational delivery in a complex, multi-stakeholder environment (e.g., clinical trials, healthcare services, logistics, consulting).
- Experience owning a conversion funnel or delivery pipeline end-to-end, including measuring drop-off, identifying bottlenecks, and improving throughput.
- Track record of scaling an operational function in a fast-growing organization by building repeatable processes, reducing cycle times, and increasing capacity.
- Experience coordinating across multiple external partners and internal teams across countries, cultures, and time zones.
- Strong analytical skills, including dashboard creation, Excel proficiency, PowerPoint presentations, and data-driven operational decision-making.
- Structured project management discipline with the ability to manage multiple parallel workstreams to deadline.
- High energy and comfort with ambiguity in a startup environment.
Skills
- Operational delivery
- Funnel management
- Pipeline management
- Process scaling
- Cross-functional coordination
- Analytical skills
- Data analysis
- Project management
- Stakeholder management
Location
- US
Work Type
- Full-time
Experience Level
- 5-8 years
About the Company
- Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating barriers of geography, financial constraints, and information asymmetry.
- Founded in 2015 and headquartered in the US, Massive Bio is scaling its impact globally.
- The company partners with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting-edge therapies.
